Osteogenic differentiation of human bone marrow-derived mesenchymal stem cells is enhanced by an aragonite scaffold

Bone graft substitutes and bone void fillers are predominantly used to treat bone defects and bone fusion in orthopaedic surgery. Some aragonite-based scaffolds of coralline exoskeleton origin exhibit osteoconductive properties and are described as useful bone repair scaffolds. The purpose of this s...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Matta Csaba
Somogyi Csilla
Kon Elizaveta
Robinson Dror
Neufeld Tova
Berta Ágnes
Altschuler Nir
Hangody László
Veréb Zoltán
Zákány Róza
Dokumentumtípus: Cikk
Megjelent: 2019
Sorozat:DIFFERENTIATION 107
doi:10.1016/j.diff.2019.05.002

mtmt:30686163
Online Access:http://publicatio.bibl.u-szeged.hu/18314
LEADER 02908nab a2200313 i 4500
001 publ18314
005 20200228101408.0
008 200228s2019 hu o 0|| zxx d
022 |a 0301-4681 
024 7 |a 10.1016/j.diff.2019.05.002  |2 doi 
024 7 |a 30686163  |2 mtmt 
040 |a SZTE Publicatio Repozitórium  |b hun 
041 |a zxx 
100 1 |a Matta Csaba 
245 1 0 |a Osteogenic differentiation of human bone marrow-derived mesenchymal stem cells is enhanced by an aragonite scaffold  |h [elektronikus dokumentum] /  |c  Matta Csaba 
260 |c 2019 
300 |a 24-34 
490 0 |a DIFFERENTIATION  |v 107 
520 3 |a Bone graft substitutes and bone void fillers are predominantly used to treat bone defects and bone fusion in orthopaedic surgery. Some aragonite-based scaffolds of coralline exoskeleton origin exhibit osteoconductive properties and are described as useful bone repair scaffolds. The purpose of this study was to evaluate the in vitro osteogenic potential of the bone phase of a novel aragonite-based bi-phasic osteochondral scaffold (Agili-C™, CartiHeal Ltd.) using adult human bone marrow-derived mesenchymal stem cells (MSCs). Analyses were performed at several time intervals: 3, 7, 14, 21, 28 and 42 days post-seeding. Osteogenic differentiation was assessed by morphological characterisation using light microscopy after Alizarin red and von Kossa staining, and scanning electron microscopy. The transcript levels of alkaline phosphatase (ALP), runt-related transcription factor 2 (RUNX2), bone gamma-carboxyglutamate (BGLAP), osteonectin (SPARC) and osteopontin (SPP1) were determined by quantitative PCR. Proliferation was assessed by a thymidine incorporation assay and proliferating cell nuclear antigen (PCNA) immunocytochemistry. Our results demonstrate that the bone phase of the bi-phasic aragonite-based scaffold supports osteogenic differentiation and enhanced proliferation of bone marrow-derived MSCs at both the molecular and histological levels. The scaffold was colonized by differentiating MSCs, suggesting its suitability for incorporation into bone voids to accelerate bone healing, remodelling and regeneration. The mechanism of osteogenic differentiation involves scaffold surface modification with de novo production of calcium phosphate deposits, as revealed by energy dispersive spectroscopy (EDS) analyses. This novel coral-based scaffold may promote the rapid formation of high quality bone during the repair of osteochondral lesions. 
700 0 1 |a Somogyi Csilla  |e aut 
700 0 1 |a Kon Elizaveta  |e aut 
700 0 1 |a Robinson Dror  |e aut 
700 0 1 |a Neufeld Tova  |e aut 
700 0 1 |a Berta Ágnes  |e aut 
700 0 1 |a Altschuler Nir  |e aut 
700 0 1 |a Hangody László  |e aut 
700 0 1 |a Veréb Zoltán  |e aut 
700 0 1 |a Zákány Róza  |e aut 
856 4 0 |u http://publicatio.bibl.u-szeged.hu/18314/1/1-s2.0-S0301468119300040-main1.pdf  |z Dokumentum-elérés